{'fraction_non_alphanumeric': 0.033660589060308554, 'fraction_numerical': 0.019635343618513323, 'mean_word_length': 4.578125, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Proton Pump Inhibitors for Laryngopharyngeal Reflux: What Do We Know?

The first proton pump inhibitor (PPI) came on the market thirty years ago. As of 2019, there are 6 commercially available generic PPIs approved by the United States Food and Drug Administration (FDA) [1] under several brand names (Table 1). PPIs work to reduce the amount of gastric acid in the stomach and prevent the movement of acid into the esophagus. Specifically, PPIs inhibit the action of the proton pump which is the last process of creating and excreting stomach acid [2]. They are effective in blocking acid secretion by up to 99 percent and offer up to 76% symptom relief [3]. Table 1: Proton Pump Inhibitors in the United States.